Literature DB >> 19871058

QUANTITATIVE STUDIES OF PROSTATIC SECRETION : II. THE EFFECT OF CASTRATION AND OF ESTROGEN INJECTION ON THE NORMAL AND ON THE HYPERPLASTIC PROSTATE GLANDS OF DOGS.

C Huggins1, P J Clark.   

Abstract

Cystic hyperplasia of the prostate occurs spontaneously in senile dogs only when they possess physiologically effective amounts of androgenic hormone. The cysts are closely grouped and radially arranged in a conical manner with the base of the cone at the periphery of the gland. Flattened and columnar epithelium, varying from about 5 to 25micro are seen in each cyst. The cysts communicate with the urethra by way of ducts. Both normal and cystic prostates undergo marked atrophy when the testes are removed, the chief difference 3 months after orchiectomy being the persistence of slightly dilated clefts and spaces at the site of the former cysts in the senile state. In the castrate dog whose prostate gland is being reconstructed as result of the influence of daily injections of androgen, certain doses of estrogen prevent increase of secretion and still larger doses greatly depress the output of the gland. In dogs so treated by daily injections of testosterone propionate, 10 mg., the amount of secretion is maintained from day to day at a level by daily injections of stilbestrol, 0.4 to 0.6 mg. and greatly depressed by doses of 1 to 1.5 mg. When the larger amounts of estrogen are used, together with androgen, squamous metaplasia occurs in the posterior lobe of the prostate while the epithelium of the acini decreases in height to cuboidal or low columnar form; these histological signs of activity of both androgen and estrogen on the prostate show that inhibition of the male hormone by stilbestrol is incomplete at these ratios. In dogs with either normal or cystic prostate glands, the prostate decreases in size when estrogen is injected in amounts to depress prostatic secretion profoundly. The gland is maintained in an atrophic state and overdosage avoided by controlled periodic injections of stilbestrol until secretion is reduced to the minimum, followed by free intervals, the estrogen being again administered when secretion measurably increases. The shrinkage is related to depression of male hormone production. Overdosage of estrogen causes the prostate gland of dogs to enlarge, and structures of the posterior lobe and utriculus respond first and most markedly with metaplasia caused by this material. The prostatic enlargement does not resemble the common cystic hyperplasia of senile dogs. Metaplasia rapidly disappears from the prostate, and the epithelial structures quickly return to normal when estrogen is discontinued and androgen is administered.

Entities:  

Year:  1940        PMID: 19871058      PMCID: PMC2135039          DOI: 10.1084/jem.72.6.747

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Effect of Oestradiol Benzoate on the Amount of Gonadotrophin in Pituitary Gland and Urine of Post-menopausal Women.

Authors:  I W Rowlands; E P Sharpey-Schafer
Journal:  Br Med J       Date:  1940-02-10

2.  The effect of oestrone on normal and castrated male rats.

Authors:  V Korenchevsky; M Dennison
Journal:  Biochem J       Date:  1934       Impact factor: 3.857

3.  The effect of prolonged dosage with oestrogens on the adult brown leghorn cock.

Authors:  C W Emmens
Journal:  J Physiol       Date:  1939-04-14       Impact factor: 5.182

4.  Further observations on the effects of sex hormones on the prostate and seminal vesicles of monkeys.

Authors:  S Zuckerman; O C Sandys
Journal:  J Anat       Date:  1939-07       Impact factor: 2.610

5.  The Effects of Oestrone on the Prostate and Uterus Musculinus of Various Species of Primate.

Authors:  S Zuckerman; A S Parkes
Journal:  J Anat       Date:  1936-04       Impact factor: 2.610

6.  The Effects of Prolonged Oestrogenic Stimulation on the Prostate of the Rhesus Monkey.

Authors:  S Zuckerman
Journal:  J Anat       Date:  1938-01       Impact factor: 2.610

7.  INTERACTIONS BETWEEN VARIOUS STEROID HORMONES.

Authors:  H Selye
Journal:  Can Med Assoc J       Date:  1940-02       Impact factor: 8.262

8.  The Endocrine Control of the Prostate: (Section of Urology).

Authors:  S Zuckerman
Journal:  Proc R Soc Med       Date:  1936-10

9.  Old Age in Relation to Cell-Overgrowth and Cancer.

Authors:  E W Goodpasture; G B Wislocki
Journal:  J Med Res       Date:  1916-01

10.  QUANTITATIVE STUDIES OF PROSTATIC SECRETION : I. CHARACTERISTICS OF THE NORMAL SECRETION; THE INFLUENCE OF THYROID, SUPRARENAL, AND TESTIS EXTIRPATION AND ANDROGEN SUBSTITUTION ON THE PROSTATIC OUTPUT.

Authors:  C Huggins; M H Masina; L Eichelberger; J D Wharton
Journal:  J Exp Med       Date:  1939-11-30       Impact factor: 14.307

  10 in total
  37 in total

Review 1.  A history of prostate cancer treatment.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

2.  The ultrastructure of the accessory sex organs of the male rat. 7. The effect of an anti-androgenic compound, SK and F 22340.

Authors:  K J Tveter; E Dahl
Journal:  Urol Res       Date:  1975

3.  [Hormone-dependent tumors; clinical and experimental studies].

Authors:  C HUGGINS
Journal:  Klin Wochenschr       Date:  1958-12-01

4.  Intralbugineous testicular prosthesis, a new technique. Summary of 30 implants.

Authors:  R G Aguilera; J P López; R R Aldosa; G Rius-Espina
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

5.  Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Authors:  M Tsugaya; F K Habib; G D Chisholm; M Ross; K Tozawa; Y Hayashi; K Kohri; S Tanaka
Journal:  Urol Res       Date:  1996

6.  Oestrogens in the treatment of cancer.

Authors:  E C DODDS
Journal:  Postgrad Med J       Date:  1948-06       Impact factor: 2.401

7.  The role of oestrogen therapy in the treatment of prostatic cancer.

Authors:  J D FERGUSSON
Journal:  Postgrad Med J       Date:  1948-06       Impact factor: 2.401

8.  Benign nodular hyperplasia of the prostate; a review.

Authors:  L M FRANKS
Journal:  Ann R Coll Surg Engl       Date:  1953-02       Impact factor: 1.891

9.  The Use of Stilboestrol in the Treatment of Carcinoma of the Prostate.

Authors:  J Chesney
Journal:  Postgrad Med J       Date:  1944-12       Impact factor: 2.401

10.  Mice lacking β-carotene-15,15'-dioxygenase exhibit reduced serum testosterone, prostatic androgen receptor signaling, and prostatic cellular proliferation.

Authors:  Joshua W Smith; Nikki A Ford; Jennifer M Thomas-Ahner; Nancy E Moran; Eric C Bolton; Matthew A Wallig; Steven K Clinton; John W Erdman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.